Browsing by Author Skarlos, D. V.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 19 to 24 of 24 < previous 
TitleAuthor(s)Issue date???itemlist.???
A randomised phase III trial of adjuvant radio-chemotherapy comparing Irinotecan, 5FU and Leucovorin to 5FU and Leucovorin in patients with rectal cancer: a Hellenic Cooperative Oncology Group StudyKalofonos, H. P.; Bamias, A.; Koutras, A.; Papakostas, P.; Basdanis, G.; Samantas, E.; Karina, M.; Misailidou, D.; Pisanidis, N.; Pentheroudakis, G.; Economopoulos, T.; Papadimitriou, C.; Skarlos, D. V.; Pectasides, D.; Stavropoulos, M.; Bafaloukos, D.; Kardamakis, D.; Karanikiotis, C.; Vourli, G.; Fountzilas, G.24-Nov-2015-
Randomized comparison of early versus late hyperfractionated thoracic irradiation concurrently with chemotherapy in limited disease small-cell lung cancer: A randomized phase II study of the Hellenic Cooperative Oncology Group (HeCOG)Skarlos, D. V.; Samantas, E.; Briassoulis, E.; Panoussaki, E.; Pavlidis, N.; Kalofonos, H. P.; Kardamakis, D.; Tsiakopoulos, E.; Kosmidis, P.; Tsavdaridis, D.; Tzitzikas, J.; Tsekeris, P.; Kouvatseas, G.; Zamboglou, N.; Fountzilas, G.24-Nov-2015-
A randomized trial to compare the efficacy and safety of antiemetic treatment with ondansetron and ondansetron zydis in patients with breast cancer treated with high-dose epirubicinPectasides, D.; Dafni, U.; Aravantinos, G.; Timotheadou, E.; Skarlos, D. V.; Pavlidis, N.; Gaglia, A.; Kalofonos, H. P.; Fountzilas, G.24-Nov-2015-
Trastuzumab combined with pegylated liposomal doxorubicin in patients with metastatic breast cancer. phase II Study of the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluationChristodoulou, C.; Kostopoulos, I.; Kalofonos, H. P.; Lianos, E.; Bobos, M.; Briasoulis, E.; Gogas, H.; Razis, E.; Skarlos, D. V.; Fountzilas, G.24-Nov-2015-
Triple-negative phenotype is of adverse prognostic value in patients treated with dose-dense sequential adjuvant chemotherapy: a translational research analysis in the context of a Hellenic Cooperative Oncology Group (HeCOG) randomized phase III trialSkarlos, P.; Christodoulou, C.; Kalogeras, K. T.; Eleftheraki, A. G.; Bobos, M.; Batistatou, A.; Valavanis, C.; Tzaida, O.; Timotheadou, E.; Kronenwett, R.; Wirtz, R. M.; Kostopoulos, I.; Televantou, D.; Koutselini, E.; Papaspirou, I.; Papadimitriou, C. A.; Pectasides, D.; Gogas, H.; Aravantinos, G.; Pavlidis, N.; Arapantoni, P.; Skarlos, D. V.; Fountzilas, G.24-Nov-2015-
Weekly alternating non-cross-resistant chemotherapy for small cell lung cancer with a good prognosis: a study of the Hellenic Cooperative Oncology GroupSkarlos, D. V.; Samantas, E.; Pectasides, D.; Pavlidis, N.; Kalofonos, C.; Klouvas, G.; Panoussaki, E.; Tsiakopoulos, E.; Poulakis, N.; Fountzilas, G.24-Nov-2015-